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Abstract: Primary malignant cardiac tumors (cardiac angiosarcomas) are exceedingly rare. 
Since there are initially nonspeciﬁ  c or missing symptoms, these tumors are usually diagnosed 
only in an advanced, often incurable stage, after the large tumor mass elicits hemodynamic 
obstructive symptoms. A 59-year-old female presented with symptoms of cerebral ischemia. 
A computed tomography (CT) scan showed changes suggestive of stroke. Transesophageal 
echocardiography revealed an inhomogeneous, medium-echogenic, ﬂ  oating mass at the 
roof of the left atrium near the mouth of the right upper pulmonary vein, indicative of a 
thrombus. At surgery, a solitary tumor was completely enucleated. Histologically, cardiac 
angiosarcoma was diagnosed. The patient received adjuvant chemotherapy and was free of 
symptoms and recurrence of disease at 14 months follow-up. Due to the fortuitous appearance 
of clinical signs indicative of stroke, cardiac angiosarcoma was diagnosed and effectively 
treated at an early, nonmetastatic, and therefore potentially curable stage. Although cardiac 
angiosarcoma is a rare disease, it should be taken into consideration as a potential cause of 
cerebral embolic disease.
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Introduction
Cardioembolic stroke is a major and frequent complication of various cardiac diseases. 
By far the most common cardiac sources of embolic stroke include atrial ﬁ  brillation, 
ischemic heart disease, mechanical prosthetic valves, and rheumatic heart disease. 
Nonischemic dilated cardiomyopathy, infective endocarditis, thrombotic vegetations, 
myxomatous mitral valve, paradoxical embolism, atrial septal aneurism, mitral anular 
calciﬁ  cation, calciﬁ  c aortic stenosis, and left atrial cardiac tumors (ie, myxoma) are 
further causes of cardioembolic disease (Hart 1992). In addition, malignant primary 
cardiac tumors are an exceedingly rare cause of cardioembolic stroke. Primary cardiac 
tumors themselves are generally infrequent. Among these tumors, benign lesions (ie, 
myxomas or rhabdomyomas) predominate. Within the malignancies, sarcomas and 
especially angiosarcomas represent the most common entities (Mayer et al 2007; Yu 
et al 2007). Here we present a case of a cardiac angiosarcoma that was diagnosed and 
effectively treated at an early stage due to clinical signs of stroke.
Case report
A 59-year-old woman was admitted to the hospital due to a sudden onset of occipital 
headache, nausea and dizziness. A cerebral computed tomography (CT) scan con-
ﬁ  rmed a cerebellar (embolic) ischemic stroke. The patient was transmitted to the 
stroke unit, and a routine diagnostic procedure to evaluate the origin of the embolism 
was carried out. A duplex-sonographic scan of the brain-supplying arteries revealed Vascular Health and Risk Management 2008:4(4) 938
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Figure 1 Transesophageal echocardiography showing a ﬂ  oating mass in the left atrium.
no abnormalities. Atrial ﬁ  brillation as a potential source of 
cardiac emboli could not be demonstrated during 24-hour 
Holter monitoring. Transesophageal echocardiography 
(TEE) revealed a 1.5 cm ﬂ  oating mass that originated from 
the roof of the left atrium, near the mouth of right upper 
pulmonary vein (Figure 1), strongly suggestive of a ﬂ  oating 
thrombus. The remaining cardiac structures were free of 
abnormalities. The patient was immediately sent to cardiac 
surgery, where the operation was performed the same day. 
A polycystic villous tumor with a smooth, fatty consistency 
around a hard core was enucleated and removed in toto.
Microscopically, a tumor with broad necrosis lined by 
a thin rim of densely packed tumor cells was diagnosed. 
These tumor cells were highly polymorphic and showed 
rounded or spindle-shaped nuclei with prominent nucleoli. 
Single multinucleated giant cells also could be observed. The 
mitotic rate was as high as 5 mitoses per high-power ﬁ  eld, 
including atypical mitotic ﬁ  gures. Focally, the tumor showed 
little vascular channels with some erythrocytes within the 
lumina (Figure 2a).
Immunohistochemically, tumor cells strongly expressed 
endothelial markers such as factor XIII, CD31, CD34, as well 
as vimentin (Figure 2b). Cytokeratins, desmin and smooth 
muscle actin were negative. Reaction with MIB-1 revealed a 
high proliferation rate, with up to 30% of tumor cells positive 
for MIB-1 (Figure 2c). The tumor was diagnosed as a poorly 
differentiated angiosarcoma of the left atrium.
Following surgical removal of the tumor, the patient 
was moved to the Department of Oncology. With additional 
diagnostic procedures including CT and magnetic resonance 
imaging (MRI), a systemic or metastatic malignancy was 
ruled out. The patient was given an adjuvant anthracycline-
containing chemotherapy and discharged on day 23 after 
surgery.Vascular Health and Risk Management 2008:4(4) 939
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Figure 2b Immunohistochemical expression of CD31 (Brown colour, original magniﬁ  cation × 200).
Routine follow-up including CT, MRI, and TEE at 6 and 
12 months revealed no evidence of metastastic or recurrent 
disease, and the patient was free of symptoms at 14 months 
post-surgery.
Discussion
Primary tumors of the heart are rare, being found in less than 
0.3% of autopsies. The incidence of these tumors has been 
reported to be 0.001% to 0.03% (Glancy et al 1968). Cardiac 
Figure 2a Microscopic analysis of a specimen from the atrial mass disclosed highly polymorphic tumor cells and vascular channels (arrow) with erythrocytes (H&E, Original 
magniﬁ  cation × 200).Vascular Health and Risk Management 2008:4(4) 940
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angiosarcoma accounts for less than 10% of all primary 
tumors of the heart (McAllister 1979; Putnam et al 1991; 
Burke and Virmani 1996; Yu et al 2007), but it is the most 
frequent malignant primary tumor of the heart with a relative 
incidence of about 33% in adults (Allard et al 1995; Neragi-
Miandoab et al 2007). This tumor usually originates in the 
right atrium. The majority of patients are middle-aged, with 
men being at higher risk than women (Janigan et al 1986; 
Hart 1992; Neragi-Miandoab et al 2007). Because of the 
presence of multiple metastases at the time of diagnosis, the 
tumor is associated with a very poor prognosis (Janigan et al 
1986; Putnam et al 1991). Because of its rarity, no generally 
applicable guidelines for treatment have been established. 
Surgery, adjuvant chemotherapy and radiation have been 
used, but despite these aggressive therapeutic strategies, 
most patients die within one year after diagnosis (Mayer et al 
2007). Although the usual cause of death is congestive heart 
failure, early cardiac transplantation is not recommended 
because of the frequent presence of metastases at time of 
diagnosis (Burke et al 1992; Reardon et al 2006).
Tumors of the heart result in a wide range of clinical signs 
and symptoms. The clinical presentation often depends on 
the anatomic localization, rather than the size, of the tumor. 
A large inﬁ  ltrative tumor of the myocardium may be clinical 
silent, yet a small, strategically placed lesion may cause dra-
matic symptoms. Tumors of the left atrium that are mobile, 
especially myxomas, may prolapse into the mitral valve, 
causing obstruction of the blood ﬂ  ow with resulting symp-
toms of mitral valve disease. Cardiac angiosarcomas also 
have a high incidence of complications, including embolic 
phenomena (Butany et al 2005; Murinello et al 2007).
The neurological consequences of embolisation include 
transient ischemic attacks, seizures, syncope and cerebral, 
cerebellar, brain stem, spinal cord, or retinal infarction. 
The neurological event may be the ﬁ  rst or only clinical 
sign of a cardiac tumor (Hart 1992; Butany et al 2005). 
Since new image technologies have been introduced, the 
source of cardioembolic stroke has been identiﬁ  ed much 
more frequently. These technologies, especially TEE and, 
more recently, cardiovascular MRI, also allow an earlier 
diagnosis of cardiac tumors, notably when associated with 
symptoms of stroke (Brandt et al 2005; Schwab et al 2006). 
In the present case, differentiation between a tumor and 
simple thrombus was difﬁ  cult with TEE because the tumor 
mass was small and embedded in extensive necrosis together 
with secondly added thrombotic material. Cardiovascular 
Figure 2c High proliferation index with MIB-1 (Brown coloured nuclei, original magniﬁ  cation × 200).Vascular Health and Risk Management 2008:4(4) 941
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MRI can now provide more detailed information on the 
possible benign or malignant quality of the cardiac tumor 
(Brandt et al 2006), but noninvasive imaging techniques 
do not yet allow a deﬁ  nitive diagnosis, which can only be 
achieved histologically. However, the power of new imaging 
technologies is evident in the improvement in antemortem 
diagnosis in recent years. In 1968, cardiac angiosarcoma 
was successfully diagnosed antemortem in only four of 41 
cases (9.8%) (Glancy et al 1968). This rate increased to 55 
of 67 (82.1%) cases in 2000 (Butany and Yu 2000), and is 
liable to improve further.
Conclusion
This report describes an unusual cardiac angiosarcoma, 
localized in the left atrium, that came to the attention of cli-
nicians due to an embolic stroke. The origin of the embolus 
was established as a cardiac tumor by transesophageal echo-
cardiography, which was followed by the surgical removal 
of the tumor and histopathological examination. Surgical 
removal of the tumor was the basis for effective therapy 
that served to prevent recurrent embolic events, and as the 
initial treatment of the malignancy. Adjuvant chemotherapy 
completed the therapeutic regime. In summary, sensitive 
imaging technologies can facilitate the early detection and 
treatment of otherwise fatal disorders. Furthermore, the 
favorable outcome presented in this case underscores the 
beneﬁ  ts of interdisciplinary cooperation among physicians 
for effective patient care.
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